|
AU2016200807A1
|
|
Method of producing biologically active vitamin K dependent proteins by recombinant methods
|
|
CN107531774A
|
|
Mankind's Coagulation factor VIII gene expression cassette of optimization and application thereof
|
|
WO2016126928A1
|
|
Quantum dot light emitting devices
|
|
WO2016123474A1
|
|
Methods to generate gastrointestinal epithelial tissue constructs
|
|
US2016145549A1
|
|
System and method for hazardous drug surface cleaning
|
|
WO2016115382A1
|
|
Methods and compositions for targeted gene transfer
|
|
WO2016115319A1
|
|
Methods, systems, and computer readable media for generating and using a web page classification model
|
|
WO2016111935A1
|
|
Simple release strategy for surface captured cells and compounds
|
|
WO2016103190A1
|
|
Combined local delivery of therapeutic agents using interventional devices and radiation
|
|
US2016168140A1
|
|
Heterocyclic compounds as antibiotic potentiators
|
|
WO2016094461A1
|
|
Methods, systems, and computer readable media for estimating the index of cerebral oxygen metabolism (i-com) using magnetic resonance (mr) imaging
|
|
WO2016090250A1
|
|
Compositions and methods for preventing and treating graft versus host disease
|
|
WO2016099814A1
|
|
Optimization of configuration of u-type fluidic systems for uniform flow distribution
|
|
CN107532173A
|
|
Target the AAV carriers of central nervous system
|
|
WO2016073827A1
|
|
High efficiency dye sensitized photoelectrosynthesis cells
|
|
WO2016073837A1
|
|
Methods and compositions for modified factor ix proteins
|
|
WO2016073557A1
|
|
Minimal-latency tracking and display for matching real and virtual worlds
|
|
WO2016070008A1
|
|
Hepatitis b reporter viruses and cccdna-based expression vectors
|
|
CN107206046A
|
|
The inhibitor peptides of the sodium channel of improvement
|
|
WO2016055927A1
|
|
Methods and apparatus for synthetic gas production having controlled hydrogen gas and carbon monoxide ratios in aqueous media
|
